Background: Bedside tests for C-reactive protein (CRP) have been studied in pediatric patients, but not in neonates.
Introduction
Neonatal sepsis is a systemic disease, characterized by massive microbial invasion followed by a systemic inflammatory response (1) (2) (3) . It affects 15%-30% of newborn infants admitted to the neonatal intensive care unit, particularly very low birth weight infants, with high mortality (2) . Because the suspicion of sepsis in the neonate is often based on non-specific clinical signs, several predictive laboratory parameters have been investigated, including white blood cell count, tumor necrosis factor, interleukin-6, serum amyloid A, procalcitonin and C-reactive protein (CRP) (4) (5) (6) (7) (8) . Serial CRP measurements are also used to monitor the evolution of bacterial diseases because CRP concentration drops quickly in response to effective treatment (9) . Monitoring CRP concentration can lead to shorter antibiotic regimens or, alternatively, can alert one to the likelihood of complications and help predict outcome, even earlier than clinical signs (10) . Conventional laboratory methods for CRP can be unavailable in urgent situations, or may not provide results in a timely manner. They usually require at least 1 mL of blood and are uncomfortable if used for serial measurements in newborn infants. Rapid bedside quantitative assays for CRP that require insignificant amount of blood have been developed recently. Unfortunately, no data has been published about their use in the neonatal period, apart from the short report by Makhoul and coworkers on late-onset sepsis (11) . The aim of this study was to compare the diagnostic accuracy between two rapid bedside tests for CRP compared with the laboratory method, and provide information about their reliability in newborn infants.
Materials and methods

Study population
This prospective observational study was conducted from March to September 2008, in the Division of Neonatology at our University Hospital. The study was approved by our Institutional Ethical Board. We included all newborns who developed clinically suspected sepsis during the first month of life. Infants were confined to open cots or incubators, depending on their weight. For each infant we collected gestational age, birth weight, age and weight when sepsis was first suspected, hematocrit and CRP values. Work-up for sepsis included blood, urine and cerebrospinal fluid cultures for all infants. Culture of bronchoalveolar lavage fluid was also performed in infants that were ventilated.
Laboratory methods
A 1 mL blood sample was drawn from the peripheral vein for CRP measurements. CRP was measured on the same sample, using our central laboratory method (CRP-Lab) and two different bedside tests, each requiring ;3 min to obtain the result. Our central laboratory measures CRP by the 
Results
A total of 72 blood samples were obtained for measurement of CRP concentrations. These samples were collected from 43 infants during 52 episodes of workup of suspected sepsis performed between 1 and 28 days of life (median 11, interquartile range 5-22 days). Gestational age and birth weight of the 43 infants were 33"5 weeks (range 25-41 weeks) and 2250"950 g (range 510-4180 g).
In the 36 samples with CRP-Lab concentrations G10 mg/L only one had CRP-Q -10 mg/L and two had CRP-N -10 mg/L. In the 36 samples with CRP-Lab levels -10 mg/L, seven had a CRP-Q )10 mg/L and six had a CRP-N )10 mg/L. The specificity, sensitivity and predictive values are shown in Table 1 .
Passing-Bablok regression yielded an equation of ys1.0734xq1.8110 for CRP-Q and ys0.8759xq 0.9522 for CRP-N (see Figure 1) . The slope and the intercept were not significantly different from 1 and 0, respectively. The Cusum test confirmed no significant deviation from linearity (p)0.10). Bias for both assays vs. CRP-Lab was evaluated using Bland-Altman plots and is shown in Figure 2 
Discussion
Sepsis remains one of the main causes of neonatal morbidity and mortality and is particularly true for very low birth weight infants (13, 14) . In the study published by Stoll and coworkers in 2002, of 6215 very low birth infants who survived beyond 3 days, 21% had one or more episodes of sepsis with a mortality rate of 18% (14) . Antimicrobial treatment is often started on the basis of non-specific clinical signs because an early diagnosis can be crucial to optimize patient outcome. This attitude implies a widespread tendency for antibiotic abuse with the consequent risk of antimicrobial resistance. Between the several laboratory parameters that are predictive of sepsis, CRP has been thoroughly investigated because it can be detected within 6-12 h following the onset of the inflammatory process, and it peaks more quickly than other acute phase reactants (15, 16) . However, the amount of blood and the time to obtain results from the central laboratory can constitute important limitations to serial CRP measurements in neonates with suspected sepsis. Despite the development of rapid quantitative bedside assays for CRP requiring an insignificant amount of blood, the short report by Makhoul and coworkers on late-onset sepsis is the only one published about their use in the neonatal period (11) . Some authors studied the usefulness of CRP determinations in neonatal sepsis, but they did not use bedside tests (4, 8, 17, 18) . Others studied bedside tests in pediatric patients, but not in neonates (19) (20) (21) (22) . For these reasons, we designed this prospective study to compare the diagnostic accuracy between two rapid bedside tests for CRP compared with a laboratory method and to provide information concerning their reliability in newborn infants.
Considering CRP values G10 mg/L to be positive, both bedside tests have good specificity (Quick-Read 80.5%, NycoCard 83.3%), and an even better sensitivity (Quick-Read 97.2%, NycoCard 94.4%), when compared with our CRP-Lab. The agreement of measurement with the central laboratory values as estimated by Passing-Bablok analysis is high for both the bedside tests, without significant differences between them. The slope was 1.0734 for Quick-Read and 0.8759 for NycoCard. Both Passing-Bablok regression and Bland-Altman analysis showed that Quick-Read and NycoCard have no statistically significant systematic proportional bias. Univariate regression analysis showed that gestational age, birth weight, hematocrit and day of life have no influence on the agreement of measurement between the bedside tests and the central laboratory assay. The accuracy of measurements for both the bedside tests is affected only by very high CRP concentrations ()100 mg/L). This finding was more evident for the NycoCard than for the QuickRead test. Interestingly, this observation is in agreement with that of Cohen et al. (20) who found relevant quantitative discrepancies between the CRP-N and their CRP-Lab for CRP concentrations )150 mg/L. However, this limitation is of little clinical relevance considering that only four out of 72 of our study samples showed CRP concentrations )100 mg/L.
In conclusion, we provide evidence that both the Quick-Read test and the NycoCard test have excellent correlation with a validated CRP assay in newborn infants. They have high sensitivity and specificity, require a very small amount of blood, and are easy to use at the bedside of the patient. Also, they provide highly reliable results in -5 min. These characteristics allow them to be used for serial determinations of CRP concentrations in newborn infants, and can be of great help for clinicians for diagnosing and managing neonatal sepsis.
